Adverse effects of cancer therapy. Risk of secondary neoplasms
Journal Article
·
· Am. J. Pediatr. Hematol./Oncol.; (United States)
OSTI ID:6707542
Due to the long latency period for solid tumor induction (median 12-13 years), the radiation-induced malignancies now being observed are mostly related to the era of kilovoltage irradiation. Some tumors, such as thyroid cancer, have very low, if any, threshold dose for tumor induction. Sarcomas appear to require higher doses (approximately 100 rads) for induction. Controversy exists as to whether high doses of irradiation are less carcinogenic than lower doses due to greater cell killing at high doses. Acute leukemia has been induced by either irradiation alone or chemotherapy alone. Current intensive therapy protocols using combinations of chemotherapy and radiotherapy, or prolonged chemotherapy, are more leukemogenic, with the 4-year actuarial risk of leukemia in the range 4-17%. Immunosuppression due to various disease states or treatments had been accompanied by malignant tumors, often lymphomas in unusual sites such as the central nervous system. Unusual non-Hodgkin's lymphomas have recently been observed in patients treated for Hodgkin's disease, suggesting that some secondary neoplasms in cancer patients are related to immunosuppression.
- Research Organization:
- Division of Radiation Therapy, Standford University Medical Center, CA
- OSTI ID:
- 6707542
- Journal Information:
- Am. J. Pediatr. Hematol./Oncol.; (United States), Journal Name: Am. J. Pediatr. Hematol./Oncol.; (United States) Vol. 4:1; ISSN APHOD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Second neoplasms following radiotherapy or chemotherapy for cancer
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience
Journal Article
·
Sun Jan 31 23:00:00 EST 1982
· Am. J. Clin. Oncol.; (United States)
·
OSTI ID:6704794
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience
Journal Article
·
Fri Feb 28 23:00:00 EST 1986
· J. Clin. Oncol.; (United States)
·
OSTI ID:5528637
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience
Journal Article
·
Sun Jul 01 00:00:00 EDT 1984
· J. Clin. Oncol.; (United States)
·
OSTI ID:6201535
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
560151 -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CELL KILLING
DELAYED RADIATION EFFECTS
DISEASES
DOSE-RESPONSE RELATIONSHIPS
DOSES
HEMIC DISEASES
IMMUNOSUPPRESSION
LATENCY PERIOD
LEUKEMIA
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SARCOMAS
SIDE EFFECTS
THERAPY
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
560151 -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CELL KILLING
DELAYED RADIATION EFFECTS
DISEASES
DOSE-RESPONSE RELATIONSHIPS
DOSES
HEMIC DISEASES
IMMUNOSUPPRESSION
LATENCY PERIOD
LEUKEMIA
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PATIENTS
RADIATION DOSES
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SARCOMAS
SIDE EFFECTS
THERAPY